Elmwood Wealth Management’s Xenon Pharmaceuticals XENE Stock Holding History

Elmwood Wealth Management’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$593K	Buy	9,817 +10	+0.1%	+$555	0.15%	115
2026 Q1	$570K	Sell	9,807 -950	-9%	-$43.8K	0.16%	113
2025 Q4	$482K	Sell	10,757 -150	-1%	-$6.3K	0.15%	116
2025 Q3	$438K	Buy	10,907 +83	+0.8%	+$2.92K	0.16%	104
2025 Q2	$339K	Sell	10,824 -183	-2%	-$5.97K	0.13%	106
2025 Q1	$369K	Hold	11,007	–	–	0.15%	105
2024 Q4	$431K	Buy	11,007 +3,400	+45%	+$141K	0.17%	102
2024 Q3	$299K	Sell	7,607 -336	-4%	-$13.5K	0.12%	117
2024 Q2	$310K	Hold	7,943	–	–	0.14%	105
2024 Q1	$342K	Sell	7,943 -2,126	-21%	-$97.8K	0.15%	104
2023 Q4	$464K	Hold	10,069	–	–	0.33%	75
2023 Q3	$344K	Hold	10,069	–	–	0.17%	102
2023 Q2	$388K	Sell	10,069 -4,925	-33%	-$196K	0.18%	95
2023 Q1	$537K	Hold	14,994	–	–	0.25%	91
2022 Q4	$591K	Hold	14,994	–	–	0.3%	91
2022 Q3	$541K	Hold	14,994	–	–	0.27%	87
2022 Q2	$456K	Hold	14,994	–	–	0.26%	88
2022 Q1	$458K	Sell	14,994 -3,086	-17%	-$92.4K	0.23%	88
2021 Q4	$565K	Buy	+18,080	New	+$540K	0.27%	87
2021 Q2	$349K	Hold	18,729	–	–	0.18%	89
2021 Q1	$335K	Buy	+18,729	New	+$317K	0.2%	87
2020 Q3	$235K	Hold	18,729	–	–	0.19%	82
2020 Q2	$235K	Hold	18,729	–	–	0.19%	82
2020 Q1	$91.8K	Hold	18,729	–	–	0.09%	107
2019 Q4	$246K	Hold	18,729	–	–	0.21%	82
2019 Q3	$169K	Hold	18,729	–	–	0.17%	81
2019 Q2	$185K	Hold	18,729	–	–	0.16%	85
2019 Q1	$190K	Hold	18,729	–	–	0.18%	86
2018 Q4	$118K	Hold	18,729	–	–	0.11%	101
2018 Q3	$247K	Sell	18,729 -18,729	-50%	-$217K	0.21%	84
2018 Q2	$264K	Buy	37,458 +18,729	+100%	+$116K	0.24%	83
2018 Q1	$91.8K	Buy	+18,729	New	+$69.2K	0.09%	107

Other funds holding XENE

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Elmwood Wealth Management's XENE Position: Q2 2026 in Review

Elmwood Wealth Management increased its Xenon Pharmaceuticals (XENE) stake by 0.1% in Q2 2026, buying an estimated $555 and bringing the position to 9,817 shares worth $593K. The position accounts for 0.15% of the portfolio, ranked #115.

Elmwood Wealth Management first reported a position in XENE in Q1 2018 and has held it in 32 quarters since. 48 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Elmwood Wealth Management held 9,817 shares of Xenon Pharmaceuticals worth $593K as of Q2 2026.
Elmwood Wealth Management bought 10 Xenon Pharmaceuticals shares in Q2 2026, an estimated $555.
Xenon Pharmaceuticals made up 0.15% of Elmwood Wealth Management's portfolio in Q2 2026, its #115 holding.
Elmwood Wealth Management first reported a position in Xenon Pharmaceuticals in Q1 2018 and has held it in 32 quarters since.
48 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Elmwood Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.